Move Accelerates Commercialization of Subsidiary Companies’ Products SALT LAKE CITY, April 23, 2019 — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical intervention through precision therapeutic treatments, announces that it has integrated the sales and marketing team from FlagshipHealth Group, a Predictive consultant […]

Expansion of ISO 7, GMP/GTP lab allows for continued scale of production to meet demand, and new R&D facility accelerates product expansion SALT LAKE CITY (March 28, 2019) – Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent precision therapeutic intervention, announces it has completed […]

Addition of CAP/CLIA laboratory and experienced diagnostics team form an unparalleled molecular clinical and research facility to accelerate new product development, commercialization and scale SALT LAKE CITY (March 26, 2019) – Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic […]

Seven-term U.S. Senator and 25-year financial services executive bring considerable legal, financial and governance expertise to the Board of Directors SALT LAKE CITY, March 19, 2019 (GLOBE NEWSWIRE) — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, […]

Juneau Biosciences reports its recent findings relating to the genetics of endometriosis in four presentations at SRI Salt Lake City (March 14, 2019) — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that Juneau Biosciences is delivering four scientific […]

Juneau Biosciences to discuss its recent findings relating to the genetics of endometriosis in four presentations at SRI Salt Lake City (March 7, 2019) — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that Juneau Biosciences will […]

Salt Lake City (March 5, 2019) — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that its subsidiary Predictive Biotech sponsored the 5th Annual Perinatal Stem Cell Society Congress held February 28 through March 1, 2019 in Salt Lake […]

30-year healthcare veteran brings considerable financial and governance expertise Salt Lake City (February 28, 2019) — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that Jay M. Moyes has been named to the company’s Board as an […]

Revenue jumps 216% for the quarter to $10.7 million versus the prior year; and up 246% for the six month period to $18.8 million with $2.0 million in positive cash flow from operations Salt Lake City (February 15, 2019) — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease […]

Salt Lake City, UT — December 26, 2017 — Predictive Technology Group, Inc. (OTC PINK: PRED) announces that John E. Sorrentino will chair the Predictive Therapeutics’ Scientific Advisory Board. Predictive Therapeutics, a wholly owned subsidiary of Predictive Technology Group, Inc.,specializes in genetic testing, diagnostics, and therapeutic products to advance precision medicine. Sorrentino is Vice President and Chief […]